Pfizer And BioNTech Say Vaccine Trial For Kids Shows Its Safe And Effective

Enlarge this image


A health worker administers a dose of a Pfizer COVID-19 vaccine during a vaccination clinic earlier this month at the Reading Area Community College in Reading, Pa.





Matt Rourke/AP



hide caption



toggle caption


Matt Rourke/AP



Back To School: Live Updates
A Vaccine For Children Is Not Likely To Be Approved Until The End Of Year

That is likely still several months away. Parents and caregivers will likely have to wait until the end of 2021 before a COVID-19 vaccine is fully approved for young children ages 5 to 11, Dr. Francis Collins, director of the National Institutes of Health, recently told NPR.

Trial results for children under 5 years of age could come later this year, the pharmaceutical companies said.

Pfizer and BioNtech are hoping to get the trial’s data submitted to regulatory authorities soon.

«Already in March 2021, we have started the study to evaluate the immunization of younger children. Our objective was to generate and submit the data for schoolkids to regulatory authorities around the world before the winter season begins, Ugur Sahin, CEO and co-founder of BioNTech, said.

• COVID 19


• Pfizer-BioNTech


• coronavirus


• Vaccines